Hims slams pharma in Super Bowl ad, most GLP-1 patients discontinue treatment, exenatide fails to treat Parkinson's, PepsiCo shifts to healthier snacking, and more!
The Gut Punch Weekly #6
Hims slams pharma in Super Bowl ad, most GLP-1 patients discontinue treatment, exenatide fails to treat Parkinson's, PepsiCo shifts to healthier snacking, and more!